PFM

Privium Fund Management Portfolio holdings

AUM $464M
1-Year Est. Return 124.83%
This Quarter Est. Return
1 Year Est. Return
+124.83%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$464M
AUM Growth
+$79.9M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
63
New
Increased
Reduced
Closed

Top Buys

1
+$24.2M
2
+$6.79M
3
+$2.67M
4
AMZN icon
Amazon
AMZN
+$1.76M
5
SHOP icon
Shopify
SHOP
+$1.71M

Top Sells

1
+$23.1M
2
+$7.13M
3
+$6.76M
4
SWTX
SpringWorks Therapeutics
SWTX
+$5.47M
5
QURE icon
uniQure
QURE
+$1.84M

Sector Composition

1 Consumer Discretionary 30.56%
2 Technology 23.32%
3 Healthcare 20.84%
4 Communication Services 18.3%
5 Financials 5.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SBSW icon
51
Sibanye-Stillwater
SBSW
$9.07B
$248K 0.05%
34,040
DYN icon
52
Dyne Therapeutics
DYN
$2.34B
$239K 0.05%
27,566
ALXO icon
53
ALX Oncology
ALXO
$88.4M
$221K 0.05%
509,059
FATE icon
54
Fate Therapeutics
FATE
$178M
$127K 0.03%
111,090
+2,064
VYGR icon
55
Voyager Therapeutics
VYGR
$296M
$78.8K 0.02%
25,241
+3,596
AIG icon
56
American International
AIG
$42.7B
– –
-6,483
ALNY icon
57
Alnylam Pharmaceuticals
ALNY
$63.1B
– –
-5,716
CPNG icon
58
Coupang
CPNG
$57.4B
– –
-81,900
IMVT icon
59
Immunovant
IMVT
$3.03B
– –
-72,000
NET icon
60
Cloudflare
NET
$73.7B
– –
-60,000
NTLA icon
61
Intellia Therapeutics
NTLA
$2.67B
– –
-58,709
SNOW icon
62
Snowflake
SNOW
$81.3B
– –
-48,000
SWTX
63
DELISTED
SpringWorks Therapeutics
SWTX
– –
-123,980
1 2
3